Persistent gut motor dysfunction in a murine model of T-cell-induced enteropathy

Neurogastroenterology and Motility

Volumn 22, Issue 2, 2010, Pages

  Mizutani, T ^a   Akiho, H ^a   Khan, W I ^b   Murao, H ^a   Ogino, H ^a   Kanayama, K ^a   Nakamura, K ^a   Takayanagi, R ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

5 hydroxytryptamine; Enteritis; Interleukin 13; Interleukin 4; Intestinal motility

Indexed keywords

CARBACHOL; CD3 ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENTERITIS; ENTEROCHROMAFFIN CELL; ENTEROPATHY; EXPERIMENTAL MODEL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE MOTILITY; INTESTINE MUSCLE; IRRITABLE COLON; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMALL INTESTINE; SMOOTH MUSCLE CONTRACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE INJURY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD3; CELL COUNT; CYTOKINES; DISEASE MODELS, ANIMAL; ENTERITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL MOTILITY; IMMUNOHISTOCHEMISTRY; INTESTINES; MALE; MICE; MUSCLE CONTRACTION; SEROTONIN; T-LYMPHOCYTES; TIME FACTORS;

EID: 74549150594     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01396.x     Document Type: Article

References (49)

1. Akiho H, Deng Y, Blennerhassett P, Kanbayashi H, Collins SM. Mechanism underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology 2005 129 : 131 141.
2. Demedts I, Geboes K, Kindt S et al. Neural mechanisms of early postinflammatory dysmotility in rat small intestine. Neurogastroenterol Motil 2006 18 : 1102 1111.
3. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003 124 : 1662 1671.
4. Khan WI, Collins SM. Gut motor function: immunological control in enteric infection and inflammation. Clin Exp Immunol 2006 143 : 389 397.
5. Akiho H, Lovato P, Deng Y, Ceponis PJ, Blennerhassett P, Collins SM. Interleukin-4 and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2005 288 : G609 15.
6. Annese V, Bassotti G, Napolitano G, Usai P, Andriulli A, Vantrappen G. Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol 1997 32 : 1107 1117.
7. Moreels TG, De Man JG, De Winter BY, Timmermans JP, Herman AG, Pelckmans PA. Effect of 2,4,6-trinitrobenzenesulphonic acid (TNBS)-induced ileitis on the motor function of non-inflamed rat gastric fundus. Neurogastroenterol Motil 2001 13 : 339 352.
8. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001 120 : 652 668.
9. Chadwick VC, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002 122 : 1778 1783.
10. Spiller RC, Jenkins D, Thornley JP et al. Increased mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000 47 : 804 811.
11. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003 125 : 1651 1659.
12. Gwee KA, Collins SM, Read NW et al. Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome. Gut 2003 52 : 523 526.
13. Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: Postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol 2009 7 : 48 53.
14. Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002 97 : 389 396.
15. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005 17 : 863 870.
16. Merger M, Viney JL, Borojevic R et al. Defining the roles of perforin, Fas/FasL, and tumor necrosis factor α in T-cell induced mucosal damage in the mouse intestine. Gut 2002 51 : 155 163.
17. Ferran C, Sheehan K, Dy M et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T-cell activation. Eur J Immunol 1990 20 : 509 515. (Pubitemid 20101288)
18. Wissing KM, Desalle F, Abramowicz D et al. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice. Transplantation 1999 68 : 677 684.
19. Farmer SG, Laniyonu AA. Effects of p-chlorophenylalanine on the sensitivity of rat intestine to agonists and on intestinal 5-hydroxytryptamine levels during Nippostrongylus brasiliensis infection. Br J Pharmacol 1984 82 : 883 889.
20. Bitar KN, Makhlouf GM. Receptors on smooth muscle cells: characterization by contraction and specific antagonists. Am J Physiol 1982 242 : G400 7.
21. Akiho H, Blennerhassett P, Deng Y, Collins SM. Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol 2002 282 : G226 32.
22. Radojevic N, Mckay DM, Merger M, Vallance BA, Collins SM, Croitoru K. Characterization of enteric functional changes evoked by in vivo anti-CD3 T-cell activation. Am J Physiol 1999 276 : R715 23.
23. Miura N, Yamamoto M, Fukutake M et al. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T-cell compartments. Int Immunol 2005 17 : 513 522.
24. Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord 2003 3 (Suppl. 2 S25 34.
25. Akiho H, Murao H, Ogino H et al. Role of acecylcholine and serotonin receptors in the maintenance of muscle hypercontractility in a murine model of post inflammatory irritable bowel syndrome. Gastroenterology 2008 134 (Suppl. 1 A-9.
26. Vallance BA, Croitoru K, Collins SM. T lymphocyte-dependent and independent intestinal smooth muscle dysfunction in the T. spiralis-infected mouse. Am J Physiol 1998 275 : G1157 65.
27. Khan WI, Vallance BA, Blennerhassett PA et al. Critical role for signal transduction and activation of transcription factor 6 in mediating intestinal muscle hypercontractility and worm expulsion in Trichinella spiralis-infected mice. Infect Immun 2001 69 : 838 844.
28. Hansen MB. Neurohumoral control of gastrointestinal motility. Physiol Res 2003 52 : 1 30.
29. Hansen MB, Skadhauge E. Signal transduction pathways for serotonin as an intestinal secretagogue. Comp Biochem Physiol 1997 A 118 : 283 290.
30. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996 111 : 1683 1699.
31. + lymphocytes during small intestinal inflammation. Gut 2006 55 : 492 497.
32. + T-cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut 2007 56 : 949 957.
33. Motomura Y, Ghia JE, Wang H et al. Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments. Gut 2008 57 : 475 481.
34. 2A receptor in nematode infection-induced murine intestinal smooth muscle hypercontractility. Gastroenterology 2006 131 : 568 578.
35. Akiho H, Khan WI, Al-Kaabi A, Blennerhassett P, Deng Y, Collins SM. Cytokine modulation of muscarinic receptors in the murine intestine. Am J Physiol Gastrointest Liver Physiol 2007 293 : G250 5.
36. Taniyama K, Nakayama S, Takeda K et al. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 1991 258 : 1098 1104.
37. 4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998 115 : 370 380.
38. Satoh K, Hayakawa T, Kase Y et al. Mechanisms for contractile effect of Dai-kenchu-to in isolated guinea pig ileum. Dig Dis Sci 2001 46 : 250 256. (Pubitemid 32242671)
39. 7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology 2005 129 : 1557 1566.
40. Wells RW, Blennerhassett MG. Persistent and selective effects of inflammation on smooth muscle cell contractility in rat colitis. Pflugers Arch Eur J Phisiol 2004 448 : 515 524.
41. Zhao A, Urban JF, Robert M et al. Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 2008 135 : 217 225.
42. Vermillon DL, Huzinga JD, Riddell RH, Collins SM. Altered small intestinal smooth muscle function in Crohn's disease. Gastroenterology 1993 104 : 1692 1699.
43. Koch TR, Carney JA, Go VL, Szurszewski JH. Spontaneous contraction and some electrophysiologic properties of circular muscle from normal sigmoid colon and ulcerative colitis. Gastroenterology 1988 95 : 77 84.
44. Cao W, Vrees MD, Kirber MT, Fiocchi C, Pricolo VE. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2004 286 : G833 43.
45. Kyosola K, Penttila O, Salaspuro M. Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol 1977 12 : 363 367.
46. Bishop AE, Pietroletti R, Taat CW, Brummelkamp WH, Polak JM. Increased populations of endocrine cells in Crohn's ileitis. Virchows Arch A Pathol Anat Histopathol 1987 410 : 391 396.
47. El Salhy M, Danielsson A, Stenling R, Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 1997 242 : 413 419.
48. Spiller R. Serotonin and GI clinical disorders. Neuropharmacology 2008 55 : 1072 1080.
49. Minderhoud IM, Oldenburg B, Schipper ME, Ter Linde JJM, Samsom M. Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission. Clin Gastroenterol Hepatol 2007 5 : 714 720.